# RTN4R

## Overview
The RTN4R gene encodes the reticulon 4 receptor, commonly referred to as the Nogo-66 receptor, which is a glycosylphosphatidylinositol (GPI)-anchored cell surface receptor. This receptor is primarily involved in the central nervous system (CNS), where it plays a critical role in regulating axonal growth and regeneration by forming a receptor complex with co-factors such as LINGO-1 and either p75 or TROY, members of the tumor necrosis factor receptor family (Hsu2007Nogo). The RTN4R protein is characterized by its leucine-rich repeat (LRR) domain, essential for binding ligands like Nogo-A, myelin-associated glycoprotein (MAG), and oligodendrocyte-myelin glycoprotein (OMgp), which collectively inhibit neurite outgrowth and contribute to neural network stability (Fournier2001Identification; Schwab2010Functions). The gene is located on chromosome 22q11.2, a region linked to neuropsychiatric disorders such as schizophrenia, highlighting its clinical significance (Sinibaldi2004Mutations).

## Structure
The RTN4R protein, also known as the Nogo-66 receptor, is characterized by its leucine-rich repeat (LRR) domain, which is essential for ligand binding. The protein consists of an extracellular N-terminal ectodomain with eight LRRs and a membrane-anchored C-terminal domain containing a glycosylphosphatidylinositol (GPI) anchor sequence (Hsu2007Nogo). The LRR domain is flanked by an N-terminal cap and a C-terminal subdomain, which includes a cysteine-rich LRR carboxy-terminal flanking domain (Fournier2001Identification). The ectodomain is crucial for binding the RTN4 ligand, while the C-terminal domain, which includes the GPI sequence and a connecting 'stalk', is necessary for interaction with co-factors such as p75 (Hsu2007Nogo).

RTN4R forms a heteromeric receptor complex with LINGO-1 and either p75 or TROY, a member of the tumor necrosis factor receptor family, to initiate signaling cascades that inhibit axonal growth (Hsu2007Nogo). The protein is attached to the plasma membrane via a GPI moiety, which is not essential for its function, as demonstrated by chimeric proteins that can still promote growth cone collapse (McGee2003The). The RTN4R gene is located within the 22q11.2 locus, and several variants have been identified, including non-conservative changes in conserved amino acids (Hsu2007Nogo).

## Function
The RTN4R gene encodes the Nogo receptor 1, a glycosylphosphatidylinositol-linked (GPI-linked) cell surface molecule that plays a crucial role in the central nervous system (CNS) by regulating axonal growth and regeneration. RTN4R forms a heteromeric receptor complex with co-factors such as LINGO-1 and either p75 or TROY, which are part of the tumor necrosis factor receptor family. This complex initiates a signaling cascade that activates RhoA, leading to the inhibition of axonal growth (Hsu2007Nogo). RTN4R acts as a convergence point for several myelin-associated growth inhibitory factors, including oligodendrocyte-myelin glycoprotein (OMgp), myelin-associated glycoprotein (MAG), and Nogo-A, which limit neurite outgrowth and regeneration (Hsu2007Nogo).

In healthy human cells, RTN4R is involved in maintaining neural network stability by preventing excessive or aberrant growth in the CNS. It plays a role in stabilizing neural circuits during early development, which is crucial for maintaining CNS integrity and function (Hsu2007Nogo; Schwab2010Functions). The receptor is primarily active in neurons, contributing to the regulation of neural plasticity and repair processes (Schwab2010Functions).

## Clinical Significance
Mutations and alterations in the RTN4R gene have been implicated in several neuropsychiatric disorders, particularly schizophrenia. The RTN4R gene is located on chromosome 22q11.2, a region associated with schizophrenia susceptibility. Studies have identified rare missense mutations in RTN4R, such as R119W, R196H, and R292H, which may contribute to schizophrenia risk by affecting the receptor's function and interactions (Kimura2017A; Sinibaldi2004Mutations). The R292H mutation, in particular, has been shown to affect growth cone formation, a critical process in neurodevelopment, and is associated with schizophrenia susceptibility (Kimura2017A).

Alterations in RTN4R expression have also been observed in schizophrenia, with some studies reporting down-regulation of related proteins in postmortem brain analyses (Hsu2007Nogo). These changes may influence the clinical expression of schizophrenia in a subset of patients, potentially modulating genetic risk (Hsu2007Nogo). The RTN4R gene's involvement in neuronal connectivity and myelin-related processes further underscores its significance in the pathophysiology of schizophrenia and other neurodevelopmental disorders (Kimura2017A). Despite these findings, the exact role of RTN4R in schizophrenia remains to be fully elucidated, necessitating further research to clarify its contribution to disease susceptibility and progression (Hsu2007Nogo).

## Interactions
The RTN4R gene encodes the Nogo-66 receptor, which is involved in several key interactions within the nervous system. RTN4R forms a receptor complex with p75NTR and LINGO-1, which is crucial for transducing inhibitory signals that affect axonal growth. This complex responds to ligands such as Nogo-A, myelin-associated glycoprotein (MAG), and oligodendrocyte-myelin glycoprotein (OMgp), all of which bind to the leucine-rich repeat (LRR) domain of RTN4R (Hsu2007Nogo; Mi2004LINGO1).

RTN4R interacts with Nogo-66, a domain of the Nogo protein, to inhibit axonal regeneration. This interaction is mediated by the high-affinity binding of Nogo-66 to the RTN4R receptor, which is anchored to the cell surface via a glycosylphosphatidylinositol (GPI) linkage (Fournier2001Identification). The receptor complex, including RTN4R, p75NTR, and LINGO-1, activates the small GTPase RhoA, leading to growth inhibition (Mi2004LINGO1).

OMgp also acts as a ligand for RTN4R, sharing overlapping binding regions with Nogo-66 on the receptor. This interaction similarly results in the inhibition of neurite outgrowth, highlighting the role of RTN4R as a convergence point for multiple inhibitory signals in the central nervous system (Wang2002Oligodendrocytemyelin).


## References


[1. (Sinibaldi2004Mutations) Lorenzo Sinibaldi, Alessandro De Luca, Emanuele Bellacchio, Emanuela Conti, Augusto Pasini, Claudio Paloscia, Gianfranco Spalletta, Carlo Caltagirone, Antonio Pizzuti, and Bruno Dallapiccola. Mutations of the nogo-66 receptor (rtn4r) gene in schizophrenia. Human Mutation, 24(6):534–535, 2004. URL: http://dx.doi.org/10.1002/humu.9292, doi:10.1002/humu.9292. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.9292)

[2. (Schwab2010Functions) Martin E. Schwab. Functions of nogo proteins and their receptors in the nervous system. Nature Reviews Neuroscience, 11(12):799–811, November 2010. URL: http://dx.doi.org/10.1038/nrn2936, doi:10.1038/nrn2936. This article has 312 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nrn2936)

[3. (Wang2002Oligodendrocytemyelin) Kevin C. Wang, Vuk Koprivica, Jieun A. Kim, Rajeev Sivasankaran, Yong Guo, Rachel L. Neve, and Zhigang He. Oligodendrocyte-myelin glycoprotein is a nogo receptor ligand that inhibits neurite outgrowth. Nature, 417(6892):941–944, June 2002. URL: http://dx.doi.org/10.1038/nature00867, doi:10.1038/nature00867. This article has 743 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature00867)

[4. (Fournier2001Identification) Alyson E. Fournier, Tadzia GrandPre, and Stephen M. Strittmatter. Identification of a receptor mediating nogo-66 inhibition of axonal regeneration. Nature, 409(6818):341–346, January 2001. URL: http://dx.doi.org/10.1038/35053072, doi:10.1038/35053072. This article has 881 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/35053072)

[5. (McGee2003The) Aaron W. McGee and Stephen M. Strittmatter. The nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends in Neurosciences, 26(4):193–198, April 2003. URL: http://dx.doi.org/10.1016/s0166-2236(03)00062-6, doi:10.1016/s0166-2236(03)00062-6. This article has 252 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0166-2236(03)00062-6)

[6. (Kimura2017A) H Kimura, Y Fujita, T Kawabata, K Ishizuka, C Wang, Y Iwayama, Y Okahisa, I Kushima, M Morikawa, Y Uno, T Okada, M Ikeda, T Inada, A Branko, D Mori, T Yoshikawa, N Iwata, H Nakamura, T Yamashita, and N Ozaki. A novel rare variant r292h in rtn4r affects growth cone formation and possibly contributes to schizophrenia susceptibility. Translational Psychiatry, 7(8):e1214–e1214, August 2017. URL: http://dx.doi.org/10.1038/tp.2017.170, doi:10.1038/tp.2017.170. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/tp.2017.170)

[7. (Hsu2007Nogo) Ruby Hsu, Abigail Woodroffe, Wen-Sung Lai, Melloni N. Cook, Jun Mukai, Jonathan P. Dunning, Douglas J. Swanson, J. Louw Roos, Gonçalo R. Abecasis, Maria Karayiorgou, and Joseph A. Gogos. Nogo receptor 1 (rtn4r) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS ONE, 2(11):e1234, November 2007. URL: http://dx.doi.org/10.1371/journal.pone.0001234, doi:10.1371/journal.pone.0001234. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0001234)

[8. (Mi2004LINGO1) Sha Mi, Xinhua Lee, Zhaohui Shao, Greg Thill, Benxiu Ji, Jane Relton, Melissa Levesque, Norm Allaire, Steve Perrin, Bryan Sands, Thomas Crowell, Richard L Cate, John M McCoy, and R Blake Pepinsky. Lingo-1 is a component of the nogo-66 receptor/p75 signaling complex. Nature Neuroscience, 7(3):221–228, February 2004. URL: http://dx.doi.org/10.1038/nn1188, doi:10.1038/nn1188. This article has 679 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nn1188)